This website uses cookies
This website uses cookies. For further information on how we use cookies you can read our Privacy and Cookie notice
This website uses cookies. For further information on how we use cookies you can read our Privacy and Cookie notice
2 units left
Easy Return, Quick Refund.Details
Dynamart KE
92%Seller Score
22 Followers
Shipping speed: Excellent
Quality Score: Excellent
Customer Rating: Average
Welcome to our shop.
Browse our entire shop here: https://www.jumia.co.ke/dynamart-ke/
Argireline Solution 10%
A 'non-injective' solution for dynamic lines.
Targets: Early Signs of Aging, Crow's Feet, Signs of Aging
Suited to: All Skin Types
Format: Serum: Water-Based
Key ingredients: Acetyl Hexapeptide-8
Ingredients
Aqua (Water), Propanediol, Acetyl Hexapeptide-8, Trisodium Ethylenediamine Disuccinate, Gellan Gum, Sodium Chloride, Isoceteth-20, Dimethyl Isosorbide, Potassium Sorbate, Phenoxyethanol, Chlorphenesin.
Our formulations are updated from time to time as part of our commitment to innovation. As such, the ingredient list shown here may vary from the box of the product depending on time and region of purchase.
Product Details
Argireline Solution 10% offers an advanced formula targeting dynamic forehead, “eleven eye”, and smile lines in an effective, “non-injective” way. By incorporating a high concentration of Argireline™ , this lightweight serum improves the appearance of facial areas prone to deep-set lines, resulting in smoother, more relaxed skin.
ARGIRELINE™ is a trademark of Lipotec S.A.U. Neither DECIEM nor The Ordinary is affiliated with Lipotec S.A.U.
How to use
Apply a few drops to the forehead and around the eyes in the morning and evening.
If irritation occurs, rinse off, cease use, and consult a physician.
Use only as directed on unbroken skin.
Patch testing prior to use is advised.
Keep out of reach of children.
Do not use with:
Direct Acids
Direct Vitamin C
Resveratrol and Ferulic Acid
Salicylic Acid
1 bottle Argireline Solution 10% 30ml
1 verified rating
This product has no reviews yet.